person · Reporting owner
Hall Patricia Hemingway
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CARDINAL HEALTH INCCAH · Entity 3014 | Director | April 15, 2026 | April 17, 2026 |
| HALLIBURTON COHAL · Entity 3141 | Director | February 28, 2022 | March 01, 2022 |
| ManpowerGroup Inc.MAN · Entity 1769 | Director | January 01, 2025 | January 03, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CARDINAL HEALTH INC
Report date April 15, 2026 · Filed April 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 28,645 |
Reported balance
After 2026-04-15 transaction · row 1
1 source rowRow 1 · 2026-04-15 · Grant · Acquired 381 · Balance 28,645 F2: Price is closing share price on March 20, 2026, which is the date on which Ms. Hemingway Hall was elevated to Chair of the Board. F1: Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026.
F2: Price is closing share price on March 20, 2026, which is the date on which Ms. Hemingway Hall was elevated to Chair of the Board.
HALLIBURTON CO
Report date February 28, 2022 · Filed March 01, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,299 |
Reported balance
After 2022-02-28 transaction · row 1
1 source rowRow 1 · 2022-02-28 · Exercise / conversion · Acquired 762 · Balance 6,299 F1: Vesting of 25% of restricted stock units granted on February 28, 2019. |
| 02/2019 Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 762 |
Reported balance
After 2022-02-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-02-28 · Exercise / conversion · Disposed 762 · Balance 762 F2: Each restricted stock unit represents a right to receive one share of the Company's common stock. F3: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting or, if reporting person elected to defer receipt, following cessation as a director. |
| 08/2019 Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,014 |
Reported balance
Holding disclosure · report date 2022-02-28 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 4,014 F2: Each restricted stock unit represents a right to receive one share of the Company's common stock. F3: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting or, if reporting person elected to defer receipt, following cessation as a director. |
| 12/2020 Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,425.48 |
Reported balance
Holding disclosure · report date 2022-02-28 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 12,425.48 F2: Each restricted stock unit represents a right to receive one share of the Company's common stock. F4: The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. |
| 12/2021 Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,849 |
Reported balance
Holding disclosure · report date 2022-02-28 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 7,849 F2: Each restricted stock unit represents a right to receive one share of the Company's common stock. F4: The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. |
Filing footnotes · ownership attribution and instrument terms
F1: Vesting of 25% of restricted stock units granted on February 28, 2019.
F2: Each restricted stock unit represents a right to receive one share of the Company's common stock.
F3: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting or, if reporting person elected to defer receipt, following cessation as a director.
F4: The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director.
ManpowerGroup Inc.
Report date January 01, 2025 · Filed January 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,659 |
Ending reported balance
After 2025-01-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-01-01 · Exercise / conversion · Acquired 2,013 · Balance 18,540 F1: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. Row 2 · 2025-01-01 · Grant · Acquired 3,119 · Balance 21,659 F2: Annual grant of restricted stock under the 2011 Equity Incentive Plan of the Company (the "Plan") and the Terms and Conditions Regarding the Grant of Awards to Non-Employee Directors under the Plan (the "Terms and Conditions"). F3: The shares of restricted stock will vest in quarterly installments on the last day of each calendar quarter during 2025. F4: Represents the Market Price (as defined in the Plan) on the last trading day of 2024. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,013 |
Reported balance
After 2025-01-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-01-01 · Grant · Acquired 85 · Balance 2,013 F5: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2025. F6: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7: Represents the Average Trading Price (as defined in the Terms and Conditions). |
| Deferred Stock UnitsSEC Table II · derivative / convertible security · Expires 2025-01-01 | Direct | 0 |
Reported balance
After 2025-01-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-01-01 · Exercise / conversion · Acquired 2,013 · Balance 0 F5: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2025. F1: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. |
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,992 |
Reported balance
After 2025-01-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-01-01 · Grant · Acquired 127 · Balance 2,992 F8: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F6: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7: Represents the Average Trading Price (as defined in the Terms and Conditions). |
Filing footnotes · ownership attribution and instrument terms
F1: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis.
F2: Annual grant of restricted stock under the 2011 Equity Incentive Plan of the Company (the "Plan") and the Terms and Conditions Regarding the Grant of Awards to Non-Employee Directors under the Plan (the "Terms and Conditions").
F3: The shares of restricted stock will vest in quarterly installments on the last day of each calendar quarter during 2025.
F4: Represents the Market Price (as defined in the Plan) on the last trading day of 2024.
F5: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2025.
F6: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends.
F7: Represents the Average Trading Price (as defined in the Terms and Conditions).
F8: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CELGENE CORP /DE/
Report date November 20, 2019 · Filed November 22, 2019
Section 16 reporting ended · disclosed 2019-11-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $91.10 · Expires 2028-04-17 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-11-20 · Disposition to issuer · Disposed 10,000 · Balance 0 F2: In connection with the Agreement and Plan of Merger (the "Merger Agreement") dated January 2, 2019, by and among Celgene Corporation ("Celgene"), Bristol-Myers Squibb Company ("BMS"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS ("Merger Sub"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the "Effective Time"), these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of contingent value rights ("CVRs"), in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement. F1: This option was fully exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.38 · Expires 2028-06-13 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-11-20 · Disposition to issuer · Disposed 13,266 · Balance 0 F2: In connection with the Agreement and Plan of Merger (the "Merger Agreement") dated January 2, 2019, by and among Celgene Corporation ("Celgene"), Bristol-Myers Squibb Company ("BMS"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS ("Merger Sub"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the "Effective Time"), these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of contingent value rights ("CVRs"), in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement. F1: This option was fully exercisable. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-11-20 · Disposition to issuer · Disposed 1,454 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of Celgene common stock. F4: Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2019-11-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-11-20 · Disposition to issuer · Disposed 4,756 · Balance 0 F3: Each restricted stock unit represents a contingent right to receive one share of Celgene common stock. F4: Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time. |
Filing footnotes · ownership attribution and instrument terms
F1: This option was fully exercisable.
F2: In connection with the Agreement and Plan of Merger (the "Merger Agreement") dated January 2, 2019, by and among Celgene Corporation ("Celgene"), Bristol-Myers Squibb Company ("BMS"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS ("Merger Sub"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the "Effective Time"), these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of contingent value rights ("CVRs"), in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement.
F3: Each restricted stock unit represents a contingent right to receive one share of Celgene common stock.
F4: Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested. The converted restricted stock units will be settled as promptly as practicable following the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 15, 2026 Filed Apr 17, 2026 11:26 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 381 | $207.83 | $79,183.23 |
DisclosureSEC source: 0000721371-26-000015 · wk-form4_1776425173.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,645 F2 · price: Price is closing share price on March 20, 2026, which is the date on which Ms. Hemingway Hall was elevated to Chair of the Board. F1 · acquired: Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026. Read SEC document |
| February 06, 2026 Filed Feb 10, 2026 21:13 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | SaleCommon Shares | 4,000 | $229.72 | $918,880.00 |
DisclosureSEC source: 0001517890-26-000002 · wk-form4_1770757977.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,264 Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 21:13 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 1,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001517890-25-000005 · wk-form4_1762463603.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,264 F1 · shares: Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:36 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 127 | $69.67 | $8,848.09 |
DisclosureSEC source: 0000950170-25-001262 · ownership.xml · derivative · entry 5 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,992 Underlying: Common Stock · 127 shares Expires not disclosed F8 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F8 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F8 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:36 UTC | ManpowerGroup Inc. MAN · Entity 1769 | Exercise / conversionDeferred Stock Units · Derivative | 2,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-001262 · ownership.xml · derivative · entry 4 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,013 shares Expires 2025-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2025. F1 · price: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:36 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 85 | $69.67 | $5,921.95 |
DisclosureSEC source: 0000950170-25-001262 · ownership.xml · derivative · entry 3 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,013 Underlying: Common Stock · 85 shares Expires not disclosed F5 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2025. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F5 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2025. F5 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2025. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:36 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantCommon Stock | 3,119 | $57.72 | $180,028.68 |
DisclosureSEC source: 0000950170-25-001262 · ownership.xml · nonDerivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,659 F2 · kind: Annual grant of restricted stock under the 2011 Equity Incentive Plan of the Company (the "Plan") and the Terms and Conditions Regarding the Grant of Awards to Non-Employee Directors under the Plan (the "Terms and Conditions"). F3 · shares: The shares of restricted stock will vest in quarterly installments on the last day of each calendar quarter during 2025. F4 · price: Represents the Market Price (as defined in the Plan) on the last trading day of 2024. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:36 UTC | ManpowerGroup Inc. MAN · Entity 1769 | Exercise / conversionCommon Stock | 2,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-001262 · ownership.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. Read SEC document |
| November 06, 2024 Filed Nov 7, 2024 21:39 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 1,730 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-24-000148 · wk-form4_1731015534.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,197 F1 · shares: Grant of restricted share units that will vest on November 6, 2025, except if the 2025 Annual Meeting of Shareholders is prior to November 6, 2025, then the restricted share units will vest on the date of the 2025 Annual Meeting of Shareholders. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:47 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 103 | $78.68 | $8,104.04 |
DisclosureSEC source: 0000950170-24-001016 · ownership.xml · derivative · entry 6 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,865 Underlying: Common Stock · 103 shares Expires not disclosed F9 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F9 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F9 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:47 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 69 | $78.68 | $5,428.92 |
DisclosureSEC source: 0000950170-24-001016 · ownership.xml · derivative · entry 5 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,928 Underlying: Common Stock · 69 shares Expires not disclosed F8 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2025 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F8 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2025 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F8 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2025 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:47 UTC | ManpowerGroup Inc. MAN · Entity 1769 | Exercise / conversionDeferred Stock Units · Derivative | 2,132 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-001016 · ownership.xml · derivative · entry 4 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,132 shares Expires 2024-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2024. F1 · price: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:47 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 77 | $78.68 | $6,058.36 |
DisclosureSEC source: 0000950170-24-001016 · ownership.xml · derivative · entry 3 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,132 Underlying: Common Stock · 77 shares Expires not disclosed F5 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2024. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F5 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2024. F5 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and were settled in shares of ManpowerGroup common stock on a 1 for 1 basis on January 1, 2024. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:47 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantCommon Stock | 2,265 | $79.47 | $179,999.55 |
DisclosureSEC source: 0000950170-24-001016 · ownership.xml · nonDerivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,527 F2 · kind: Annual grant of restricted stock under the 2011 Equity Incentive Plan of the Company (the "Plan") and the Terms and Conditions Regarding the Grant of Awards to Non-Employee Directors under the Plan (the "Terms and Conditions"). F3 · shares: The shares of restricted stock will vest in quarterly installments on the last day of each calendar quarter during 2024. F4 · price: Represents the Market Price (as defined in the Plan) on the last trading day of 2023. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:47 UTC | ManpowerGroup Inc. MAN · Entity 1769 | Exercise / conversionCommon Stock | 2,132 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-001016 · ownership.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. Read SEC document |
| November 15, 2023 Filed Nov 16, 2023 21:29 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 1,965 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-23-000107 · wk-form4_1700170120.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,467 F1 · shares: Grant of restricted share units that will vest on November 15, 2024, except if the 2024 Annual Meeting of Shareholders is prior to November 15, 2024, then the restricted share units will vest on the date of the 2024 Annual Meeting of Shareholders. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:16 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 91 | $79.56 | $7,239.96 |
DisclosureSEC source: 0001209191-23-001139 · doc4.xml · derivative · entry 4 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,762 Underlying: Common Stock · 91 shares Expires not disclosed F8 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F5 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F6 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F8 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F8 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:16 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 61 | $79.56 | $4,853.16 |
DisclosureSEC source: 0001209191-23-001139 · doc4.xml · derivative · entry 3 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,859 Underlying: Common Stock · 61 shares Expires not disclosed F7 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2025 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F5 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F6 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F7 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2025 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F7 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2025 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:16 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 68 | $79.56 | $5,410.08 |
DisclosureSEC source: 0001209191-23-001139 · doc4.xml · derivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,055 Underlying: Common Stock · 68 shares Expires not disclosed F4 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2024 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F5 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F6 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F4 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2024 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F4 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2024 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:16 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantCommon Stock | 2,103 | $83.21 | $174,990.63 |
DisclosureSEC source: 0001209191-23-001139 · doc4.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,130 F1 · kind: Annual grant of restricted stock under the 2011 Equity Incentive Plan of the Company (the "Plan") and the Terms and Conditions Regarding the Grant of Awards to Non-Employee Directors under the Plan (the "Terms and Conditions"). F2 · shares: The shares of restricted stock will vest in quarterly installments on the last day of each calendar quarter during 2023. F3 · price: Represents the Market Price (as defined in the Plan) on the last trading day of 2022. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 21:38 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 2,308 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-22-000166 · wf-form4_166811630150459.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,502 F1 · shares: Grant of restricted share units that will vest on November 9, 2023, except if the 2023 Annual Meeting of Shareholders is prior to November 9, 2023, then the restricted share units will vest on the date of the 2023 Annual Meeting of Shareholders. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 20:46 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversion02/2019 Restricted Stock Units · Derivative | 762 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006067 · form4.xml · derivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 762 Underlying: Common Stock · 762 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting or, if reporting person elected to defer receipt, following cessation as a director. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting or, if reporting person elected to defer receipt, following cessation as a director. Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 20:46 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversionCommon Stock | 762 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006067 · form4.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Vesting of 25% of restricted stock units granted on February 28, 2019. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 23:39 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 62 | $105.86 | $6,563.32 |
DisclosureSEC source: 0001209191-22-001167 · doc4.xml · derivative · entry 3 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,671 Underlying: Common Stock · 62 shares Expires not disclosed F7 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F5 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F6 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F7 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F7 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 23:39 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 46 | $105.86 | $4,869.56 |
DisclosureSEC source: 0001209191-22-001167 · doc4.xml · derivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987 Underlying: Common Stock · 46 shares Expires not disclosed F4 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2024 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F5 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F6 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F4 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2024 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F4 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2024 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 23:39 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 1,798 | $97.33 | $174,999.34 |
DisclosureSEC source: 0001209191-22-001167 · doc4.xml · derivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,798 Underlying: Common Stock · 1,798 shares Expires not disclosed F1 · derivative.exercise_price: The shares of deferred stock vest in quarterly installments on the last day of each calendar quarter during 2022 and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2025 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the "Terms and Conditions" (as defined below). F2 · kind: Annual grant of deferred stock under the 2011 Equity Incentive Plan of the Company (the "Plan") and the Terms and Conditions Regarding the Grant of Awards to Non-Employee Directors under the Plan (the "Terms and Conditions"). F3 · price: Represents the Market Price (as defined in the Plan) on the last trading day of 2021. F1 · derivative.exercise_date: The shares of deferred stock vest in quarterly installments on the last day of each calendar quarter during 2022 and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2025 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the "Terms and Conditions" (as defined below). F1 · derivative.expiration_date: The shares of deferred stock vest in quarterly installments on the last day of each calendar quarter during 2022 and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2025 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the "Terms and Conditions" (as defined below). Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 16:25 UTC | HALLIBURTON CO HAL · Entity 3141 | Grant12/2021 Restricted Stock Units · Derivative | 7,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-012608 · form4.xml · derivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,849 Underlying: Common Stock · 7,849 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. F2 · derivative.expiration_date: The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 13:06 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 3,709 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-21-000130 · wf-form4_163698158810174.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,194 F1 · shares: Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 15:55 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversion08/2019 Restricted Stock Units · Derivative | 2,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-006927 · form4.xml · derivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,014 Underlying: Common Stock · 2,007 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 15:55 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversionCommon Stock | 2,007 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-006927 · form4.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Vesting of 25% of restricted stock units granted on August 1, 2019. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 20:56 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversion02/2019 Restricted Stock Units · Derivative | 762 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002158 · form4.xml · derivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,524 Underlying: Common Stock · 762 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 20:56 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversionCommon Stock | 762 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002158 · form4.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Vesting of 25% of restricted stock units granted on February 28, 2019. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:28 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 80 | $71.31 | $5,704.80 |
DisclosureSEC source: 0001209191-21-001334 · doc4.xml · derivative · entry 5 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,609 Underlying: Common Stock · 80 shares Expires not disclosed F8 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F8 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F8 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2027 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:28 UTC | ManpowerGroup Inc. MAN · Entity 1769 | Exercise / conversionDeferred Stock Units · Derivative | 1,371 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-001334 · doc4.xml · derivative · entry 4 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,371 shares Expires 2021-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2021 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F1 · price: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:28 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 42 | $71.31 | $2,995.02 |
DisclosureSEC source: 0001209191-21-001334 · doc4.xml · derivative · entry 3 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,371 Underlying: Common Stock · 42 shares Expires not disclosed F5 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2021 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F5 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2021 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F5 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2021 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:28 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 1,941 | $90.18 | $175,039.38 |
DisclosureSEC source: 0001209191-21-001334 · doc4.xml · derivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,941 Underlying: Common Stock · 1,941 shares Expires not disclosed F2 · derivative.exercise_price: The shares of deferred stock vest in quarterly installments on the last day of each calendar quarter during 2021 and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2024 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the "Terms and Conditions" (as defined below). F3 · kind: Annual grant of deferred stock under the 2011 Equity Incentive Plan of the Company (the "Plan") and the Terms and Conditions Regarding the Grant of Awards to Non-Employee Directors under the Plan (the "Terms and Conditions"). F4 · price: Represents the Market Price (as defined in the Plan) on the last trading day of 2020. F2 · derivative.exercise_date: The shares of deferred stock vest in quarterly installments on the last day of each calendar quarter during 2021 and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2024 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the "Terms and Conditions" (as defined below). F2 · derivative.expiration_date: The shares of deferred stock vest in quarterly installments on the last day of each calendar quarter during 2021 and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2024 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the "Terms and Conditions" (as defined below). Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 22:28 UTC | ManpowerGroup Inc. MAN · Entity 1769 | Exercise / conversionCommon Stock | 1,371 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-001334 · doc4.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. Read SEC document |
| December 02, 2020 Filed Dec 3, 2020 21:07 UTC | HALLIBURTON CO HAL · Entity 3141 | Grant12/2020 Restricted Stock Units · Derivative | 12,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-006031 · form4.xml · derivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,319 Underlying: Common Stock · 12,319 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock. F2 · derivative.exercise_date: The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. F2 · derivative.expiration_date: The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. Read SEC document |
| December 01, 2020 Filed Jan 5, 2021 22:12 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GiftCommon Stock | 1,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-001276 · doc5.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,656 Read SEC document |
| November 09, 2020 Filed Nov 10, 2020 21:39 UTC | CARDINAL HEALTH INC CAH · Entity 3014 | GrantCommon Shares | 3,339 | $0.00 | $0.00 |
DisclosureSEC source: 0000721371-20-000155 · wf-form4_160504433375630.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,485 F1 · shares: Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 18:02 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversion08/2019 Restricted Stock Units · Derivative | 2,006 | $0.00 | $0.00 |
DisclosureSEC source: 0000045012-20-000099 · edgar.xml · derivative · entry 3 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,021 Underlying: Common Stock · 2,006 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 18:02 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversionCommon Stock | 2,006 | $0.00 | $0.00 |
DisclosureSEC source: 0000045012-20-000099 · edgar.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Vesting of 25% of restricted stock units granted on August 1, 2019. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 19:21 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversion02/2019 Restricted Stock Units · Derivative | 762 | $0.00 | $0.00 |
DisclosureSEC source: 0000045012-20-000039 · edgar.xml · derivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,286 Underlying: Common Stock · 762 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. F3 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning with the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 19:21 UTC | HALLIBURTON CO HAL · Entity 3141 | Exercise / conversionCommon Stock | 762 | $0.00 | $0.00 |
DisclosureSEC source: 0000045012-20-000039 · edgar.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Vesting of 25% of restricted stock units granted on February 28, 2019. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 21:40 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 60 | $90.16 | $5,409.60 |
DisclosureSEC source: 0001209191-20-001068 · doc4.xml · derivative · entry 6 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,529 Underlying: Common Stock · 60 shares Expires not disclosed F9 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2022 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F9 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2022 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F9 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2022 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 21:40 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 31 | $90.16 | $2,794.96 |
DisclosureSEC source: 0001209191-20-001068 · doc4.xml · derivative · entry 5 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,329 Underlying: Common Stock · 31 shares Expires not disclosed F8 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2021 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F8 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2021 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F8 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2021 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 21:40 UTC | ManpowerGroup Inc. MAN · Entity 1769 | Exercise / conversionDeferred Stock Units · Derivative | 1,738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-001068 · doc4.xml · derivative · entry 4 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,738 shares Expires 2020-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2020 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F4 · price: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 21:40 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantDeferred Stock Units · Derivative | 41 | $90.16 | $3,696.56 |
DisclosureSEC source: 0001209191-20-001068 · doc4.xml · derivative · entry 3 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,738 Underlying: Common Stock · 41 shares Expires not disclosed F5 · derivative.exercise_price: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2020 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F6 · kind: Receipt of deferred stock under the Plan and the Terms and Conditions in lieu of dividends. F7 · price: Represents the Average Trading Price (as defined in the Terms and Conditions). F5 · derivative.exercise_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2020 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. F5 · derivative.expiration_date: The shares of deferred stock are fully vested on the date of grant and will be settled in shares of ManpowerGroup common stock on a 1 for 1 basis on the earlier of January 1, 2020 or within 30 days after the reporting person's termination of service as a director, except as otherwise provided in the Terms and Conditions. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 21:40 UTC | ManpowerGroup Inc. MAN · Entity 1769 | Exercise / conversionCommon Stock | 1,738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-001068 · doc4.xml · nonDerivative · entry 2 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Settlement of shares of deferred stock in shares of ManpowerGroup common stock on a 1 for 1 basis. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 21:40 UTC | ManpowerGroup Inc. MAN · Entity 1769 | GrantCommon Stock | 1,802 | $97.10 | $174,974.20 |
DisclosureSEC source: 0001209191-20-001068 · doc4.xml · nonDerivative · entry 1 Hall Patricia Hemingway · CIK 0001517890 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,684 F1 · kind: Annual grant of restricted stock under the 2011 Equity Incentive Plan of the Company (the "Plan") and the Terms and Conditions Regarding the Grant of Awards to Non-Employee Directors under the Plan (the "Terms and Conditions"). F2 · shares: The shares of restricted stock will vest in quarterly installments on the last day of each calendar quarter during 2020. F3 · price: Represents the Market Price (as defined in the Plan) on the last trading day of 2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.